We reviewed the options for the manufacture and use of DNA microarrays in the original Chipping Forecast 1 in 1999. Since then, the number of companies that produce microarrays equipment and reagents ...

According to MarketsandMarketstm, the Biomarkers Market is projected to grow from about USD 67.95 billion in 2026 to USD 112.10 billion by 2031, at a CAGR of 10.5%. Browse 690 market data Tables and ...

According to MarketsandMarkets™, the Biomarkers Market is projected to grow from about USD 67.95 billion in 2026 to USD 112.10 billion by 2031, at a CAGR of 10.5%.

The widespread application of DNA microarrays to cancer research is nothing less than astounding. In the short ten-year history of this versatile technology, hundreds of large-scale experiments have ...

Raphas, a mass-production platform company specializing in microneedle technology, has teamed up with Japanese electronics ...

Scientists at ETH Zurich have identified a compound that sharply reduced nerve-cell death in mice engineered to develop ...

DelveInsight's DNA Diagnostics Market Insights report provides the current and forecast market analysis, individual leading ...

Colorectal cancer (CRC) remains one of the most heterogeneous malignancies, with substantial variability in molecular ...

PS, designed entirely by artificial intelligence, passed its first human safety trial at Cambridge — triggering ...

Discover how AI, automation, and next-generation DMTA workflows are accelerating drug discovery with expert insights from TTP leaders.

MtoZ Biolabs provides PhIP-Seq analysis support for antigen epitope screening, antibody repertoire profiling, autoantibody discovery, and biomarker research. BOSTON, MA, UNITED STATES, June 21, 2026 / ...

Scientists have now traced why the H5N1 bird flu virus that jumped into U.S. dairy herds keeps turning up in cows’ udders and ...